<SEC-DOCUMENT>0001493152-24-020696-index.html : 20240520 <SEC-HEADER>0001493152-24-020696.hdr.sgml : 20240520 <ACCEPTANCE-DATETIME>20240520162037 ACCESSION NUMBER: 0001493152-24-020696 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 EFFECTIVENESS DATE: 20240520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ProPhase Labs, Inc. CENTRAL INDEX KEY: 0000868278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 232577138 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-279545 FILM NUMBER: 24964795 BUSINESS ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 BUSINESS PHONE: (215) 345-0919 MAIL ADDRESS: STREET 1: 711 STEWART AVE, SUITE 200 STREET 2: GARDEN CITY CITY: NEW YORK STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: QUIGLEY CORP DATE OF NAME CHANGE: 19930328 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>forms-8.htm <TEXT> Document 1 - file: forms-8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>ex5-1.htm <TEXT> Document 2 - file: ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>ex23-1.htm <TEXT> Document 3 - file: ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>ex99-1.htm <TEXT> Document 4 - file: ex99-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>5 <FILENAME>ex99-2.htm <TEXT> Document 5 - file: ex99-2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>6 <FILENAME>ex107.htm <TEXT> Document 6 - file: ex107.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>ex5-1_001.jpg <TEXT> Document 7 - file: ex5-1_001.jpg
</DOCUMENT> </SEC-DOCUMENT>